Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 9/20 | 0.52 |
| ▸ | THRA | P10827 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 7/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.51 |
| ▸ | LMNA | P02545 | 5/20 | 0.51 |
| ▸ | PPARG | P37231 | 3/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | GABRP | O00591 | 1/20 | 0.51 |
| ▸ | GABRD | O14764 | 1/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
| ▸ | F2 | P00734 | 1/20 | 0.51 |
| ▸ | PCNA | P12004 | 1/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.51 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.51 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.51 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.51 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3683267 | 1.00 | THRB (0.52) | THRBTHRAMEN1KMT2ALMNA | |
| SCHEMBL951158 | 0.87 | THRB (0.52) | THRBTHRAMEN1KMT2ALMNA | |
| SCHEMBL9647408 | 0.87 | THRB (0.52) | THRBTHRAMEN1KMT2ALMNA | |
| Etilevodopa SCHEMBL1069939 | 0.87 | ALOX15 (0.64) | MEN1KMT2ALMNAPPARGCYP2D6 | |
| Etilevodopa SCHEMBL584493 | 0.87 | ALOX15 (0.64) | MEN1KMT2ALMNAPPARGCYP2D6 | |
| Etilevodopa SCHEMBL29634876 | 0.87 | ALOX15 (0.64) | MEN1KMT2ALMNAPPARGCYP2D6 | |
| Hydrochloric Acid SCHEMBL7673388 | 0.86 | ALDH1A1 (0.53) | THRBTHRAMEN1KMT2ALMNA | |
| Hydrochloric Acid SCHEMBL9662459 | 0.86 | ALDH1A1 (0.53) | THRBTHRAMEN1KMT2ALMNA | |
| SCHEMBL8160664 | 0.86 | THRB (0.51) | THRBTHRAMEN1KMT2ALMNA | |
| L-Tyrosine Ethylester SCHEMBL1574026 | 0.86 | THRB (0.47) | THRBTHRAMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11246884-B2 | Inherently radiopaque polymeric products for embolotherapy | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2022-02-15 | — | — | US | disclosed |
| US-20190142863-A1 | INHERENTLY RADIOPAQUE POLYMERIC PRODUCTS FOR EMBOLOTHERAPY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2019-05-16 | — | — | US | disclosed |
| EP-1673109-B1 | INHERENTLY RADIOPAQUE POLYMERIC PRODUCTS FOR EMBOLOTHERAPY | UNIV RUTGERS (US) | 2019-03-20 | — | — | EP | disclosed |
| US-10206946-B2 | Inherently radiopaque polymeric products for embolotherapy | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2019-02-19 | — | — | US | disclosed |
| US-10105467-B2 | Biocompatible polymer compositions for tissue void filling | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2018-10-23 | — | — | US | disclosed |
| US-20180085396-A1 | INHERENTLY RADIOPAQUE POLYMERIC PRODUCTS FOR EMBOLOTHERAPY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2018-03-29 | — | — | US | disclosed |
| US-9770465-B2 | Inherently radiopaque polymeric products for embolotherapy | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-09-26 | — | — | US | disclosed |
| US-20150335783-A1 | BIOCOMPATIBLE POLYMER COMPOSITIONS FOR TISSUE VOID FILLING | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2015-11-26 | — | — | US | disclosed |
| EP-1923075-B1 | Radiopaque polymeric stents | UNIV RUTGERS (US) | 2015-11-11 | — | — | EP | disclosed |
| US-20140255335-A1 | INHERENTLY RADIOPAQUE POLYMERIC PRODUCTS FOR EMBOLOTHERAPY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2014-09-11 | — | — | US | disclosed |
| US-20100131037-A1 | RADIOPAQUE POLYMERIC STENTS | RUTGERS , THE STATE UNIVERSITY (US) | 2010-05-27 | — | — | US | disclosed |
| EP-1673109-A4 | INHERENTLY RADIOPAQUE POLYMERIC PRODUCTS FOR EMBOLOTHERAPY | UNIV RUTGERS (US) | 2008-12-24 | — | — | EP | disclosed |
| EP-1955716-A2 | Radiopaque polymeric stents | Rutgers, The State University (US) | 2008-08-13 | — | — | EP | disclosed |
| EP-1923075-A2 | Radiopaque polymeric stents | Rutgers, The State University (US) | 2008-05-21 | — | — | EP | disclosed |
| EP-1789097-A2 | RADIOPAQUE POLYMERIC STENTS | Rutgers, The State University (US) | 2007-05-30 | — | — | EP | disclosed |
| EP-1673109-A1 | INHERENTLY RADIOPAQUE POLYMERIC PRODUCTS FOR EMBOLOTHERAPY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2006-06-28 | — | — | EP | disclosed |
| WO-2006022754-A2 | RADIOPAQUE POLYMERIC STENTS | RUTGERS, THE STATE UNIVERSITY (US) | 2006-03-02 | — | — | WO | disclosed |
| US-20060034769-A1 | Radiopaque polymeric stents | RUTGERS, THE STATE UNIVERSITY (US) | 2006-02-16 | — | — | US | disclosed |
| US-20050106119-A1 | biocompatible, bioresorption polymer containing active materials; drug delivery to body cavity | RUTGERS, THE STATE UNIVERSITY (US) | 2005-05-19 | — | — | US | disclosed |
| WO-2005030268-A1 | INHERENTLY RADIOPAQUE POLYMERIC PRODUCTS FOR EMBOLOTHERAPY | RUTGERS, THE STATE UNIVERSITY (US) | 2005-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10105467-B2 | Biocompatible polymer compositions for tissue void filling | PLOD3, AQP3, AQP1 | THRB 916/4885THRA 813/4885MEN1 3491/4885 |
| US-20140255335-A1 | INHERENTLY RADIOPAQUE POLYMERIC PRODUCTS FOR EMBOLOTHERAPY | CD47, FGB, ELANE | THRB 3375/4885THRA 2936/4885MEN1 806/4885 |
| US-20060034769-A1 | Radiopaque polymeric stents | TDO2, TYRO3, TH | THRB 1188/4885THRA 1245/4885MEN1 3190/4885 |
| US-10206946-B2 | Inherently radiopaque polymeric products for embolotherapy | CD47, FGB, ELANE | THRB 3375/4885THRA 2936/4885MEN1 806/4885 |
| US-20180085396-A1 | INHERENTLY RADIOPAQUE POLYMERIC PRODUCTS FOR EMBOLOTHERAPY | CD47, FGB, ELANE | THRB 3375/4885THRA 2936/4885MEN1 806/4885 |
| US-11246884-B2 | Inherently radiopaque polymeric products for embolotherapy | CD47, FGB, ELANE | THRB 3375/4885THRA 2936/4885MEN1 806/4885 |
| US-20190142863-A1 | INHERENTLY RADIOPAQUE POLYMERIC PRODUCTS FOR EMBOLOTHERAPY | CD47, FGB, ELANE | THRB 3375/4885THRA 2936/4885MEN1 806/4885 |
| US-20050106119-A1 | biocompatible, bioresorption polymer containing active materials; drug delivery to body cavity | CD47, CD68, MB | THRB 2932/4885THRA 1965/4885MEN1 2297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.